StacksVerified U.S. regulatory reference

21 CFR §522.1083

Verified against eCFR.gov as of June 20, 2026View official text on eCFR.gov
  1. (a)Specifications. Each milliliter (mL) of solution contains 0.2 milligrams (mg) gonadotropin releasing factor analog-diphtheria toxoid conjugate.
  2. (b)Sponsor. See No. 054771 in § 510.600(c) of this chapter.
  3. (c)Conditions of use in swine—(1) Amount. Each intact male pig or gilt should receive two 2-mL (0.4 mg) doses by subcutaneous injection. Administer the first dose no earlier than 9 weeks of age. Administer the second dose at least 4 weeks after the first dose.
    1. (2)Indications for use—(i) Intact male pigs intended for slaughter: For the temporary immunological castration (suppression of testicular function) and reduction of boar taint.
      1. (ii)Gilts intended for slaughter: For the temporary suppression of estrus.
    2. (3)Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For reduction of boar taint, intact male pigs should be slaughtered no earlier than 3 weeks and no later than 10 weeks after the second dose.